Blockchain Registration Transaction Record

Nutriband's AVERSA Fentanyl Patch Leads Abuse-Deterrent Innovation

Nutriband Inc. reports a 63% revenue increase and advances its AVERSA Fentanyl patch, aiming to revolutionize abuse-deterrent opioid treatments. Explore the impact.

Nutriband's AVERSA Fentanyl Patch Leads Abuse-Deterrent Innovation

Nutriband's development of the AVERSA(TM) Fentanyl patch represents a critical advancement in addressing the opioid crisis by offering a safer, abuse-deterrent option. This innovation could significantly reduce the potential for misuse of fentanyl patches, a pressing public health issue. The company's financial growth and strategic initiatives highlight its potential to make a meaningful impact in the pharmaceutical industry and beyond.

BlockchainDetails
Contract Address0xeA2912a8DA1CD48401b10cB283585874d98098F4
Transaction ID0x73203f50b0a5c747066eadc941f5673d94d16f615fb015b339601875cb9f5c65
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintfastWntO-8ea8dbbe9701765674d9a8de56be6771